Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
151.1 EUR | -2.43% | -0.19% | +2.92% |
Composition of VanEck Biotech ETF - USD
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| ||
---|---|---|---|---|---|---|
300.2 USD | -1.85% | -4.66% | +4.23% | 19.50% | ||
446.9 USD | -2.20% | +1.10% | +9.83% | 11.25% | ||
63.94 USD | -2.65% | -4.98% | -21.07% | 9.94% | ||
973.2 USD | -1.20% | -2.09% | +10.80% | 8.97% | ||
153.2 USD | -8.05% | +6.62% | +54.05% | 5.32% | ||
226.7 USD | -1.26% | -1.16% | -2.02% | 4.71% | ||
218.7 USD | +0.42% | -3.94% | -15.47% | 4.58% | ||
321.1 USD | +0.11% | +1.00% | +13.42% | 4.00% | ||
105 USD | -1.36% | -2.40% | -24.57% | 3.79% | ||
153.1 USD | +0.26% | -8.53% | -15.11% | 2.58% | ||
74.43 USD | -1.44% | -3.76% | -22.81% | 2.48% | ||
150.1 USD | +1.56% | +0.29% | -21.60% | 2.17% | ||
113.3 USD | -8.21% | -12.23% | +17.53% | 2.04% | ||
214.5 USD | -1.24% | -3.15% | -9.26% | 1.97% | ||
94.1 USD | -2.94% | +2.20% | -10.84% | 1.97% | ||
79.39 USD | -1.73% | -3.98% | +2.89% | 1.90% | ||
47.02 USD | -5.66% | -12.14% | -36.44% | 1.82% | ||
43.02 USD | -1.62% | -4.44% | -3.92% | 1.75% | ||
156.8 USD | -0.89% | -6.08% | -12.82% | 1.69% | ||
57.25 USD | -0.10% | -0.26% | -8.82% | 1.64% | ||
109.6 USD | +0.05% | +1.21% | +74.92% | 1.36% | ||
54.84 USD | -0.72% | +0.15% | -12.40% | 0.89% | ||
Description
US92189F7261 | |
---|---|
Total Expense Ratio | 0.35% |
Asset Class | |
Sector | |
Size | |
Currency | |
Provider | |
Underlying | MVIS US Listed Biotech 25 Net Total Return Index - USD |
Features and characteristics
Jurisdiction | |
Fund Structure | |
Replication Method | |
Replication Model | |
Date of creation |
19/12/2011
|
Dividend Policy | |
Geographical Focus |
AuM evolution ( 30/04/2024 )
AuM (EUR) | 387 M€ |
---|---|
AuM 1M | 417 M€ |
AuM 3 months | 432 M€ |
AuM 6 months | 396 M€ |
AuM 12 months | 457 M€ |
- Stock Market
- ETF
- VEFU ETF
- Components VanEck Biotech ETF - USD